Sanofi and Regeneron Win FDA Approval of Kevzara for Rheumatoid Arthritis
- Posted by Janet Tice
- On May 25, 2017
“Today’s approval…not only underscores our ongoing commitment to making a difference in the lives of patients, but also demonstrates our drive to accelerate science and medicine in immunology.” So said Sanofi Chief Executive Officer Olivier Brandicourt as Sanofi and Regeneron Pharmaceuticals announced FDA approval of Kevzara® (sarilumab) for the treatment of adults with moderate to […]
Read More